All In Biotech

Drug Trial Radar · NCT01052480

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza

A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)

Last checked: Nov 20, 2026Latest source record: Sep 5, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

98

Actual

Start

Dec 2010

Primary completion

Mar 2015

Study completion Nov 2015

Sponsor

Sponsor type
NIH
First posted
Jan 20, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized, open-label, multicenter phase 2 trial will assess the safety, efficacy, and pharmacokinetics (PK) of anti-influenza plasma in subjects with influenza A or B. Hospitalized subjects with influenza A or B that have either a low oxygen level or a high respiratory rate will be eligible for study participation. This study will enroll adults, children and pregnant women.

Conditions

  • Influenza A
  • Influenza B

Interventions

  • Anti-Influenza Immune PlasmaBiological

    2 units of plasma with high titer anti-influenza A or anti-influenza B antibodies at baseline

  • Standard CareDrug

    All subjects will receive an anti-influenza antiviral (e.g., oseltamivir or zanamivir), but may include treatment with licensed antivirals in patient populations or at doses not covered in the package insert, or with medications available under a EUA. Standard care may also include antibiotics and other medications.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Normalization of Respiratory Status (Primary Efficacy Population)Time frame: Measured from Day 0 through Day 28

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • David Geffen School of Medicine at UCLA

    Los Angeles, California

  • Naval Medical Center San Diego

    San Diego, California

  • Los Angeles Biomedical Research Institute, CA

    Torrance, California

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Washington, DC VA Med Center

    Washington D.C., District of Columbia

  • University of Florida

    Gainesville, Florida

  • Emory University Hospital

    Atlanta, Georgia

  • Northwestern University (NU)

    Chicago, Illinois

  • The Rush University Medical Center

    Chicago, Illinois

  • University of Maryland School of Medicine Center for Vaccine Development

    Baltimore, Maryland

  • John Hopkins University (JHU)

    Baltimore, Maryland

  • Walter Reed National Military Medical Center (WRNMMC)

    Bethesda, Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Brigham and Women's Hospital/Harvard Medical School

    Boston, Massachusetts

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Boston Med Center

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • University of Massachusetts Medical School

    Worcester, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Bronson Healthcare Group

    Kalamazoo, Michigan

  • Saint Mary's Hospital (Mayo Clinic)

    Rochester, Minnesota

  • Mount Sinai Medical Center

    New York, New York

  • Cornell Clinical Trials Unit, New York Presbyterian Hospital, Weill Cornell Medical College

    New York, New York

  • Montefiore Medical Center/Albert Einstein College of Medicine

    New York, New York

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • University of Cincinnati College of Medicine

    Cincinnati, Ohio

  • University Hospitals Case Medical Center

    Cleveland, Ohio

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, Pennsylvania

  • Texas Tech University Health Science Center (HSC)- Amarillo

    Amarillo, Texas

  • Texas Children's Hospital

    Houston, Texas

  • Texas Tech HSC-Lubbock, TX

    Lubbock, Texas

  • Naval Medical Center Portsmouth

    Portsmouth, Virginia

  • Madigan Army Medical Center (MAMC)

    Tacoma, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.